Faculty Summaries
Efrat Dotan, MD
Efrat Dotan, MD
Assistant Professor
Efrat.Dotan@fccc.edu
Office Phone: 215-728-2985
Fax: 215-728-3639
Office: C303

Publications

  • Namrata Vijayvergia, Efrat Dotan, Karthik Devarajan, Kamel Hatahet, Farah Rahman, Steven J. Cohen. Differences in patterns of care and outcomes of elderly versus younger metastatic pancreatic cancer (mPC) patients. J Clin Oncol 31, 2013 (suppl; abstr 9546).
  • Efrat Dotan, Tianyu LI, Michael J. Hall, Neal J. Meropol, Robert J. Beck, Yu-Ning Wong. De-adoption of epidermal growth factor receptor (EGFR) inhibitors following recommendations for KRAS testing to guide treatment of metastatic colorectal cancer (mCRC). J Clin Oncol 30, 2012 (suppl; abstr e14021)
  • Efrat Dotan, Neal Meropol, Fang Zhu, Frank Zambito, Betsy Bove, Kathy Q. Cai, Andrew K. Godwin, Erica A. Golemis, Igor Astsaturov and  Steven J. Cohen. Increased Aurora kinase A gene copy number is associated with improved prognosis and response to chemotherapy in patients with metastatic colorectal cancer. British Journal of Cancer. 2012 Feb 14;106(4):748-55.
  • Efrat Dotan, Neal J. Meropol, Barbara Burtness, Crystal S, Denlinger, James Lee, David Mintzer, Fang Zhu, Karen Ruth, Holly Tuttle, Judi Sylvester, and Steven J. Cohen. A phase II study of capecitabine, oxaliplatin, and cetuximab with or without bevacizumab as front line therapy for metastatic colorectal cancer.  A Fox Chase Extramural Research Study. J Gastrointest Cancer, December 2012, 43(4), 562-569. PMCID: PMC3400721
  • Efrat Dotan, Ilene Brown, Arti Hurria, Crystal Denlinger: Challenges in the management of elderly patients with colon cancer. JNCCN February 2012, 10(2):213-24.
  • Efrat Dotan, Lori J Goldstein, Adjuvant Chemotherapy. (Book Chapter) Advanced Therapy of Breast Disease, 3rd edition, 2012, chapter 53.
  • Efrat Dotan, Steven J. Cohen, Emmanuelle Nicolas, Karthik Devarajan, J. Robert Beck. A pilot study evaluating peripheral blood lymphocyte telomere length in elderly versus young patients with colorectal cancer (CRC). Society of Geriatric oncology 2011 and ASCO GI 2012 abstract # 512.
  • A. James D’Silva, Efrat Dotan, Karthik Devarajan, Dwight D. Kloth, Andrew Beck, Steven J. Cohen, Crystal Denlinger. Use of Anti-EGFR Agents among Elderly Patients with Metastatic Colorectal Cancer. ASCO GI 2012, abstract # 657, Journal of Geriatric Oncology Vol. 3Supplement 1, Pages S47-S48.
  • Efrat Dotan, Steven, J. Cohen. Challenges in the management of stage II colon cancer. Seminars in Oncology Aug 2011; 38(4): 511-20.
  • Efrat Dotan, Roger B. Cohen. The ongoing roll-out of aurora kinase inhibitors in cancer treatment. Drugs of the Future 2010, 35(10):845.
  • Gloria J. Morris, Efrat Dotan, Mitchell R. Smith, Frederick B. Hagemeister Jr, Harmar D. Brereton. Gastric Mucosa-Associated Lymphoid Tissue Lymphoma. Seminars in Oncology, Vol 37, No 3, June 2010, pp 183-187.
  • Efrat Dotan, Lori J Goldstein, Optimizing Chemotherapy Regimens for Patients with Early Stage Breast. Clinical Breast Cancer. Clin Breast Cancer. 2010; 10 Suppl 1:E8-15.
  • Efrat Dotan, Charu Aggarwal, Mitchell R Smith,  Impact of Rituximab on treatment of B cell Non Hodgkin’s Lymphomas. P&T Journal, March 2010 35(3): 148-157.
  • Efrat Dotan, Steven J. Cohen, Katherine R. Alpaugh, Neal J. Meropol, Circulating tumor cells: evolving evidence and future challenges. The oncologist, November 2009, 14(11): 1070-1082.
  • Efrat Dotan, Lori J Goldstein, Her-2 testing in breast cancer – reaching optimal accuracy. Women’s Health in Oncology: Focus on Breast Cancer, September 2009.
  • Efrat Dotan, Ronald N. Rubin, Woman with recent respiratory tract infection and anemia. Consultant 49(4):257-259.
  • Efrat Dotan, Randi Katz, Jason Bratche, Carrie Wasserman, Michelene Lieberman, Georgia Panagopoulos, Colette Spaccavento, The Prevalence of Pantoprazole Associated Thrombocytopenia in a Community Hospital. Expert Opinion on Pharmacotherapy, 2007, 8(13) 2025-2028.
Top